Altimmune shareholders elect all 8 director nominees, ratify auditor, approve say-on-pay

Altimmune, Inc.

All director nominees elected: votes ranged from 19.7M to 23.9M for; broker non-votes 12.6M on each.
Ernst & Young ratified as auditor for 2022: 36.4M for, 103K against, 89K abstain.
Say-on-pay advisory vote passed with 17.5M for, 6.5M against, 68K abstain, 12.6M broker non-votes.
Adjournment authorized: 26.1M for, 10.3M against, 179K abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.